Elixir launches specialty generic enhancement
PHILADELPHIA — Elixir, a wholly owned subsidiary of Rite Aid, announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up
